XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.3
Acquisitions, Disposals and Deconsolidations - Disposals and Deconsolidations (Details)
$ in Millions
9 Months Ended
Sep. 30, 2024
USD ($)
surgical_facility
Sep. 30, 2023
USD ($)
surgical_facility
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Proceeds from sales of equity investments $ 4.0 $ 1.0
Loss on sale of equity method investment 10.0  
Proceeds from disposals of facilities and other assets $ 1.5 $ 25.8
Surgical Facility, Equity Method Investment | Disposed of by Sale    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Number of interests sold | surgical_facility 1  
Proceeds from sales of equity investments $ 2.0  
Loss on sale of equity method investment $ 3.7  
Surgical Facility With A Retained Interest | Disposed of by Sale    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Number of interests sold | surgical_facility 1  
Proceeds from disposals of facilities and other assets $ 2.5  
Pre-tax gain (loss) on disposal $ 2.7  
Surgical Facility | Disposed of by Sale    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Number of interests sold | surgical_facility 1  
Pre-tax gain (loss) on disposal $ (3.4)  
2023 Disposals | Disposed of by Sale    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Number of interests sold | surgical_facility   6
Proceeds from disposals of facilities and other assets   $ 30.4
Pre-tax gain (loss) on disposal   26.9
Surgical Facilities and In-Development De Novo Surgical Facilities | Disposed of by Sale    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Proceeds from sales of equity investments   1.5
Loss on sale of equity method investment   $ 13.7